Yet for RENCA, tumor progression also yielded an overall increase in suppressive myeloid cell (MDSC) density, as well as increased expression of genes that drive monocytic MDSC immunosuppression (NOS2/iNOS, MIF, and TGFβ2) [27, 37–39]. This evidence concerns the gene NOS2 and neoplasm.